Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 192

1.

Comparative diagnostic and prognostic performances of the hematoxylin-eosin and phospho-histone H3 mitotic count and Ki-67 index in adrenocortical carcinoma.

Duregon E, Molinaro L, Volante M, Ventura L, Righi L, Bolla S, Terzolo M, Sapino A, Papotti MG.

Mod Pathol. 2014 Sep;27(9):1246-54. doi: 10.1038/modpathol.2013.230. Epub 2014 Jan 17.

2.

Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas.

Colman H, Giannini C, Huang L, Gonzalez J, Hess K, Bruner J, Fuller G, Langford L, Pelloski C, Aaron J, Burger P, Aldape K.

Am J Surg Pathol. 2006 May;30(5):657-64.

PMID:
16699322
3.

Validation of the prognostic role of the "Helsinki Score" in 225 cases of adrenocortical carcinoma.

Duregon E, Cappellesso R, Maffeis V, Zaggia B, Ventura L, Berruti A, Terzolo M, Fassina A, Volante M, Papotti M.

Hum Pathol. 2017 Apr;62:1-7. doi: 10.1016/j.humpath.2016.09.035. Epub 2016 Dec 1.

PMID:
27916625
4.

Sensitivity and usefulness of anti-phosphohistone-H3 antibody immunostaining for counting mitotic figures in meningioma cases.

Fukushima S, Terasaki M, Sakata K, Miyagi N, Kato S, Sugita Y, Shigemori M.

Brain Tumor Pathol. 2009;26(2):51-7. doi: 10.1007/s10014-009-0249-9. Epub 2009 Oct 27.

PMID:
19856215
5.

Detection of mitotic figures in thin melanomas--immunohistochemistry does not replace the careful search for mitotic figures in hematoxylin-eosin stain.

Ottmann K, Tronnier M, Mitteldorf C.

J Am Acad Dermatol. 2015 Oct;73(4):637-44. doi: 10.1016/j.jaad.2015.07.007. Epub 2015 Aug 13.

PMID:
26278815
6.

Helsinki score-a novel model for prediction of metastases in adrenocortical carcinomas.

Pennanen M, Heiskanen I, Sane T, Remes S, Mustonen H, Haglund C, Arola J.

Hum Pathol. 2015 Mar;46(3):404-10. doi: 10.1016/j.humpath.2014.11.015. Epub 2014 Dec 9.

PMID:
25582500
7.

Mitotic count by phosphohistone H3 immunohistochemical staining predicts survival and improves interobserver reproducibility in well-differentiated neuroendocrine tumors of the pancreas.

Voss SM, Riley MP, Lokhandwala PM, Wang M, Yang Z.

Am J Surg Pathol. 2015 Jan;39(1):13-24. doi: 10.1097/PAS.0000000000000341.

PMID:
25353284
8.

Immunostaining of phospho-histone H3 and Ki-67 improves reproducibility of recurrence risk assessment of gastrointestinal stromal tumors.

Uguen A, Conq G, Doucet L, Talagas M, Costa S, De Braekeleer M, Marcorelles P.

Virchows Arch. 2015 Jul;467(1):47-54. doi: 10.1007/s00428-015-1763-2. Epub 2015 Apr 1.

PMID:
25823616
9.

Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma.

Ladstein RG, Bachmann IM, Straume O, Akslen LA.

BMC Cancer. 2010 Apr 14;10:140. doi: 10.1186/1471-2407-10-140.

10.

Proliferation indices of phosphohistone H3 and Ki67: strong prognostic markers in a consecutive cohort with stage I/II melanoma.

Nielsen PS, Riber-Hansen R, Jensen TO, Schmidt H, Steiniche T.

Mod Pathol. 2013 Mar;26(3):404-13. doi: 10.1038/modpathol.2012.188. Epub 2012 Nov 23.

11.

Phosphohistone-H3 (PHH3) is prognostic relevant in Merkel cell carcinomas but Merkel cell polyomavirus is a more powerful prognostic factor than AJCC clinical stage, PHH3, Ki-67 or mitotic indices.

Iwasaki T, Matsushita M, Nonaka D, Kato M, Nagata K, Murakami I, Hayashi K.

Pathol Int. 2015 Aug;65(8):404-9. doi: 10.1111/pin.12305. Epub 2015 May 18.

PMID:
25982855
12.

Better see to better agree: phosphohistone H3 increases interobserver agreement in mitotic count for meningioma grading and imposes new specific thresholds.

Duregon E, Cassenti A, Pittaro A, Ventura L, Senetta R, Rudà R, Cassoni P.

Neuro Oncol. 2015 May;17(5):663-9. doi: 10.1093/neuonc/nov002. Epub 2015 Feb 1.

13.

Anti-phosphorylated histone H3 expression in Barrett's esophagus, low-grade dysplasia, high-grade dysplasia, and adenocarcinoma.

Goodarzi M, Correa AM, Ajani JA, Swisher SG, Hofstetter WL, Guha S, Deavers MT, Rashid A, Maru DM.

Mod Pathol. 2009 Dec;22(12):1612-21. doi: 10.1038/modpathol.2009.133. Epub 2009 Sep 4.

14.

Immunodetection of phosphohistone H3 as a surrogate of mitotic figure count and clinical outcome in cutaneous melanoma.

Tetzlaff MT, Curry JL, Ivan D, Wang WL, Torres-Cabala CA, Bassett RL, Valencia KM, McLemore MS, Ross MI, Prieto VG.

Mod Pathol. 2013 Sep;26(9):1153-60. doi: 10.1038/modpathol.2013.59. Epub 2013 Apr 5.

15.

Ki-67 proliferation index but not mitotic thresholds integrates the molecular prognostic stratification of lower grade gliomas.

Duregon E, Bertero L, Pittaro A, Soffietti R, Rudà R, Trevisan M, Papotti M, Ventura L, Senetta R, Cassoni P.

Oncotarget. 2016 Apr 19;7(16):21190-8. doi: 10.18632/oncotarget.8498.

16.

Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification.

Volante M, Bollito E, Sperone P, Tavaglione V, Daffara F, Porpiglia F, Terzolo M, Berruti A, Papotti M.

Histopathology. 2009 Nov;55(5):535-43. doi: 10.1111/j.1365-2559.2009.03423.x.

17.

Adrenocortical adenoma and carcinoma: histopathological and molecular comparative analysis.

Stojadinovic A, Brennan MF, Hoos A, Omeroglu A, Leung DH, Dudas ME, Nissan A, Cordon-Cardo C, Ghossein RA.

Mod Pathol. 2003 Aug;16(8):742-51.

18.

Comparison of the methods for measuring the Ki-67 labeling index in adrenocortical carcinoma: manual versus digital image analysis.

Yamazaki Y, Nakamura Y, Shibahara Y, Konosu-Fukaya S, Sato N, Kubota-Nakayama F, Oki Y, Baba S, Midorikawa S, Morimoto R, Satoh F, Sasano H.

Hum Pathol. 2016 Jul;53:41-50. doi: 10.1016/j.humpath.2015.10.017. Epub 2016 Mar 7.

PMID:
26980031
19.

Immunohistochemical evaluation of metallothionein, Mcm-2 and Ki-67 antigen expression in tumors of the adrenal cortex.

Szajerka A, Dziegiel P, Szajerka T, Zabel M, Winowski J, Grzebieniak Z.

Anticancer Res. 2008 Sep-Oct;28(5B):2959-65.

20.

Immunohistochemistry of a proliferation marker Ki67/MIB1 in adrenocortical carcinomas: Ki67/MIB1 labeling index is a predictor for recurrence of adrenocortical carcinomas.

Morimoto R, Satoh F, Murakami O, Suzuki T, Abe T, Tanemoto M, Abe M, Uruno A, Ishidoya S, Arai Y, Takahashi K, Sasano H, Ito S.

Endocr J. 2008 Mar;55(1):49-55. Epub 2008 Jan 10.

Supplemental Content

Support Center